Report cover image

North America Medical Second Opinion Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Publisher The Insight Partners
Published Aug 14, 2025
Length 105 Pages
SKU # TIP20476332

Description

The North America medical second opinion market is projected to grow significantly, reaching approximately USD 7,306.96 million by 2031, up from USD 2,485.58 million in 2023, with a compound annual growth rate (CAGR) of 14.4% during this period.

Executive Summary and Market Analysis

The medical second opinion market in North America is divided into three main regions: the United States, Canada, and Mexico. The growth of this market is driven by the increasing acceptance of medical second opinion services and the ongoing digital transformation in healthcare consulting. Additionally, advancements in healthcare systems and a heightened focus on improving treatment outcomes are expected to further propel market growth.

Market Segmentation Analysis

The North America medical second opinion market can be analyzed based on two key segments: medical conditions and service providers.

1. By Condition: The market is categorized into various medical conditions, including cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. Notably, the cancer segment accounted for the largest market share in 2023.

2. By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. In 2023, hospitals represented the largest share of the market.

Market Outlook

Globally, patients are facing increasing financial pressures due to rising healthcare costs, which are exacerbated by a shortage of healthcare professionals and limited resources. This situation has created a demand for healthcare cost optimization. The need for second medical opinions is growing as patients seek to avoid unnecessary surgeries and complications. Medical second opinion services provide patients with comprehensive information to make informed decisions regarding their treatment options. These services often involve a thorough review of medical records and alternative treatment assessments, which can lead to reduced healthcare costs and improved patient outcomes.

Research indicates that approximately 31% of patients experience complications from surgical procedures, and around 4.2 million postoperative deaths occur annually, highlighting the importance of second opinions in mitigating risks associated with surgery.

Country Insights

The North American medical second opinion market is primarily driven by the United States, which held the largest market share in 2023. The rising incidence of cancer, which is the second leading cause of death in the U.S., presents significant opportunities for growth in this market. In 2022, over 1.9 million new cancer cases were diagnosed, leading to approximately 609,360 deaths. Projections suggest that around 2 million new cancer cases will be diagnosed in 2024, further increasing the demand for second opinions, especially given the prevalence of misdiagnoses.

Moreover, the U.S. faces a high rate of medical errors, with around 4,000 surgical errors reported annually and 7,000 to 9,000 deaths attributed to medication errors. Approximately 795,000 Americans suffer from misdiagnoses of serious conditions each year, underscoring the critical need for second opinions in the healthcare system.

In response to these challenges, organizations like UnitedHealthcare have partnered with companies such as 2nd.MD to offer no-cost expert medical opinion services to their members. This service connects patients with specialists who review their cases and provide second opinions. Other organizations, such as WorldCare International Inc., also offer comprehensive second opinion services for critical illnesses, covering a wide range of medical conditions.

Company Profiles

Key players in the North America medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors. These companies are employing various strategies, including market expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical second opinion market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America medical second opinion market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the medical second opinion market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

105 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. North America Medical Second Opinion Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Growing Emphasis on Better Treatment Outcomes
4.1.2 Increasing Preference for Healthcare Cost Optimization
4.2 Market Restraints
4.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
4.3 Market Opportunities
4.3.1 Rising Collaborations in Telemedicine Technologies
4.4 Future Trends
4.4.1 Digitalization of Medical Consulting Services
4.5 Impact of Drivers and Restraints:
5. North America Medical Second Opinion Market – Market Analysis
5.1 North America Medical Second Opinion Market Revenue (US$ Million), 2021–2031
5.2 North America Medical Second Opinion Market Forecast Analysis
6. North America Medical Second Opinion Market Analysis – by Condition
6.1 Cancer
6.1.1 Overview
6.1.2 Cancer: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.2 Orthopedic Disorders
6.2.1 Overview
6.2.2 Orthopedic Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.3 Cardiac Disorders
6.3.1 Overview
6.3.2 Cardiac Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.4 Neurological Disorders
6.4.1 Overview
6.4.2 Neurological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.5 Nephrological Disorders
6.5.1 Overview
6.5.2 Nephrological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.6 Hematological Blood Disorders
6.6.1 Overview
6.6.2 Hematological Blood Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.7 COPD
6.7.1 Overview
6.7.2 COPD: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.8 Organ Transplant
6.8.1 Overview
6.8.2 Organ Transplant: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.9 Others
6.9.1 Overview
6.9.2 Others: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
7. North America Medical Second Opinion Market Analysis – by Service Provider
7.1 Hospitals
7.1.1 Overview
7.1.2 Hospitals: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.2 Health Insurance Companies
7.2.1 Overview
7.2.2 Health Insurance Companies: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.3 Online Services
7.3.1 Overview
7.3.2 Online Services: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
8. North America Medical Second Opinion Market – Country Analysis
8.1 North America
8.1.1 North America Medical Second Opinion Market Overview
8.1.2 North America Medical Second Opinion Market – Revenue and Forecast Analysis – by Country
8.1.2.1 North America Medical Second Opinion Market – Revenue and Forecast Analysis – by Country
8.1.2.2 United States: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1.2.2.1 United States: North America Medical Second Opinion Market Share – by Condition
8.1.2.2.2 United States: North America Medical Second Opinion Market Share – by Service Provider
8.1.2.3 Canada: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1.2.3.1 Canada: North America Medical Second Opinion Market Share – by Condition
8.1.2.3.2 Canada: North America Medical Second Opinion Market Share – by Service Provider
8.1.2.4 Mexico: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1.2.4.1 Mexico: North America Medical Second Opinion Market Share – by Condition
8.1.2.4.2 Mexico: North America Medical Second Opinion Market Share – by Service Provider
9. Industry Landscape
9.1 Overview
9.2 Market Initiative
9.3 Partnerships and Collaborations
10. Company Profiles
10.1 Second Opinion International
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Elite Medical Services
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 The Cigna Group
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Helsana
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 WorldCare
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Vidal Health Insurance TPA Pvt Ltd
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 2nd.MD
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Axa SA
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Teladoc Health Inc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Included Health, Inc.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Royal Doctors
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
11. Appendix
11.1 About Us
11.2 List of Abbreviations
List of Tables
Table 1. North America Medical Second Opinion Market Segmentation
Table 2. North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Table 3. North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Condition
Table 4. North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Provider
Table 5. North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country
Table 6. United States: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Condition
Table 7. United States: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Service Provider
Table 8. Canada: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Condition
Table 9. Canada: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Service Provider
Table 10. Mexico: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Condition
Table 11. Mexico: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Service Provider
Table 12. List of Abbreviations
LIST OF FIGURES
Figure 1. North America Medical Second Opinion Market Segmentation – Country
Figure 2. North America Medical Second Opinion Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Medical Second Opinion Market Revenue (US$ Million), 2021–2031
Figure 5. North America Medical Second Opinion Market Share (%) – by Condition (2023 and 2031)
Figure 6. Cancer: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 7. Orthopedic Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 8. Cardiac Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 9. Neurological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 10. Nephrological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 11. Hematological Blood Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 12. COPD: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 13. Organ Transplant: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 14. Others: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 15. North America Medical Second Opinion Market Share (%) – by Service Provider (2023 and 2031)
Figure 16. Hospitals: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 17. Health Insurance Companies: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 18. Online Services: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 19. North America Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 20. United States: North America Medical Second Opinion Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 21. Canada: North America Medical Second Opinion Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 22. Mexico: North America Medical Second Opinion Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us